Cardiovascular Medication Utilization and Adherence Among Heart Failure Patients in Rural and Urban Areas: A Retrospective Cohort Study

Canadian Journal of Cardiology

Volumn 31, Issue 3, 2015, Pages 341-347

  Murphy, Gaetanne K ^a   McAlister, Finlay A ^a   Eurich, Dean T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BISOPROLOL; CARVEDILOL; DIGOXIN; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; METOPROLOL; NITRIC ACID DERIVATIVE; SPIRONOLACTONE; WARFARIN; ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOTONIC AGENT; CARDIOVASCULAR AGENT; DIURETIC AGENT;

AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; DRUG UTILIZATION; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL DISCHARGE; HUMAN; ICD-9; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PRESCRIPTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY; RURAL AREA; RURAL POPULATION; TREATMENT DURATION; URBAN AREA; URBAN POPULATION; CANADA; DRUG EFFECTS; MORTALITY; TREATMENT OUTCOME; VERY ELDERLY;

ADRENERGIC ANTAGONISTS; AGED; AGED, 80 AND OVER; CANADA; CARDIOTONIC AGENTS; CARDIOVASCULAR AGENTS; DIGOXIN; DIURETICS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MEDICATION ADHERENCE; RENIN-ANGIOTENSIN SYSTEM; RETROSPECTIVE STUDIES; RURAL POPULATION; SPIRONOLACTONE; TREATMENT OUTCOME; URBAN POPULATION;

EID: 84924040891     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.11.024     Document Type: Article

References (17)

1. Hunt S.A., Abraham W.T., Chin M.H., et al. 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the International Society for Heart and Lung Transplantation. JAm Coll Cardiol 2009, 53:e1-e90.
2. Gislason G.H., Rasmussen J.N., Abildstrom S.Z., et al. Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes. Circulation 2007, 116:737-744.
3. Setoguchi S., Choudhry N.K., Levin R., Shrank W.H., Winkelmayer W.C. Temporal trends in adherence to cardiovascular medications in elderly patients after hospitalization for heart failure. Clin Pharmacol Ther 2010, 88:548-554.
4. Lamb D.A., Eurich D.T., McAlister F.A., et al. Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003. Circ Cardiovasc Qual Outcomes 2009, 2:228-235.
5. Fitzgerald A.A., Powers J.D., Ho P.M., et al. Impact of medication nonadherence on hospitalizations and mortality in heart failure. JCard Fail 2011, 17:664-669.
6. Gamble J.M., Eurich D.T., Ezekowitz J.A., et al. Patterns of care and outcomes differ for urban versus rural patients with newly diagnosed heart failure, even in a universal healthcare system. Circ Heart Fail 2011, 4:317-323.
7. Goins R.T., Williams K.A., Carter M.W., Spencer S.M., Solovieva T. Perceived barriers to health care access among rural older adults: a qualitative study. JRural Health 2005, 21:206-213.
8. Pong R., DesMeules M., Heng D., et al. Patterns of health service utilization in rural Canada. Chronic Dis Can 2011, 31(suppl 1):1-36.
9. Karve S., Cleves M.A., Helm M., et al. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin 2009, 25:2303-2310.
10. Wu J.R., Moser D.K., De Jong M.J., et al. Defining an evidence-based cutpoint for medication adherence in heart failure. Am Heart J 2009, 157:285-291.
11. Ezekowitz J.A., van Walraven C., McAlister F.A., Armstrong P.W., Kaul P. Impact of specialist follow-up in outpatients with congestive heart failure. Can Med Assoc J 2005, 172:189-194.
12. Lee D.S., Donovan L., Austin P.C., et al. Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care 2005, 43:182-188.
13. Quan H., Sundararajan V., Halfon P., et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005, 43:1130-1139.
14. Du Plessis V., Beshiri R., Bollman R.D., Clemenson H. Definitions of Rural. Rural and Small Town Canada Analysis Bulletin 2001, Vol. 3, No. 3. Statistics Canada, Ottawa.
15. Peterson A.M., Nau D.P., Cramer J.A., et al. Achecklist for medication compliance and persistence studies using retrospective databases. Value Health 2007, 10:3-12.
16. Blackburn D.F., Schnell G., Lamb D.A., et al. Coding of heart failure diagnoses in Saskatchewan: a validation study of hospital discharge abstracts. JPopul Ther Clin Pharmacol 2011, 18:e407-e415.
17. Ezekowitz J.A., Kaul P., Bakal J.A., Quan H., McAlister F.A. Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics?. Eur J Heart Fail 2011, 13:142-147.